RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma
- PMID: 25622907
- PMCID: PMC4309735
- DOI: 10.1016/j.neo.2014.12.002
RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma
Abstract
Epidermal growth factor receptor (EGFR) is overexpressed in head and neck squamous cell carcinoma (HNSCC) where it has been shown to promote tumor cell invasion upon phosphorylation. One mechanism by which EGFR promotes tumor progression is by activating signal cascades that lead to loss of E-cadherin, a transmembrane glycoprotein of the cell-cell adherence junctions; however mediators of these signaling cascades are not fully understood. One such mediator, RhoC, is activated upon a number of external stimuli, such as epidermal growth factor (EGF), but its role as a mediator of EGF-stimulated migration and invasion has not been elucidated in HNSCC. In the present study, we investigate the role of RhoC as a mediator of EGF-stimulated migration and invasion in HNSCC. We show that upon EGF stimulation, EGFR and RhoC were strongly activated in HNSCC. This resulted in activation of the phosphatidylinositol 3-Kinase Akt pathway (PI3K-Akt), phosphorylation of GSK-3β at the Ser(9) residue, and subsequent down regulation of E-cadherin cell surface expression resulting in increased tumor cell invasion. Knockdown of RhoC restored E-cadherin expression and inhibited EGF-stimulated migration and invasion. This is the first report in HNSCC demonstrating the role RhoC plays in mediating EGF-stimulated migration and invasion by down-regulating the PI3K-Akt pathway and E-cadherin expression. RhoC may serve as a treatment target for HNSCC.
Copyright © 2014 Neoplasia Press, Inc. Published by Elsevier Inc. All rights reserved.
Figures







Similar articles
-
PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.Oncotarget. 2015 Apr 10;6(10):7741-57. doi: 10.18632/oncotarget.3482. Oncotarget. 2015. PMID: 25797258 Free PMC article.
-
Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin.FASEB J. 2017 Oct;31(10):4265-4276. doi: 10.1096/fj.201700156R. Epub 2017 Jun 8. FASEB J. 2017. PMID: 28596235
-
Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.Int J Oncol. 2014 Mar;44(3):912-7. doi: 10.3892/ijo.2013.2238. Epub 2013 Dec 31. Int J Oncol. 2014. PMID: 24379084
-
Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.Expert Opin Ther Targets. 2015 Jun;19(6):795-805. doi: 10.1517/14728222.2015.1012157. Epub 2015 Feb 5. Expert Opin Ther Targets. 2015. PMID: 25652792 Review.
-
Molecular pathways in head and neck cancer: EGFR, PI3K, and more.Am Soc Clin Oncol Educ Book. 2013:246-55. doi: 10.14694/EdBook_AM.2013.33.246. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714515 Review.
Cited by
-
Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions.Int J Mol Sci. 2018 May 9;19(5):1415. doi: 10.3390/ijms19051415. Int J Mol Sci. 2018. PMID: 29747422 Free PMC article.
-
HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.Oncol Rep. 2015 Oct;34(4):1681-91. doi: 10.3892/or.2015.4194. Epub 2015 Aug 10. Oncol Rep. 2015. PMID: 26260613 Free PMC article.
-
NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion.Cancers (Basel). 2019 Mar 6;11(3):315. doi: 10.3390/cancers11030315. Cancers (Basel). 2019. PMID: 30845713 Free PMC article.
-
Long non-coding RNA MT1DP shunts the cellular defense to cytotoxicity through crosstalk with MT1H and RhoC in cadmium stress.Cell Discov. 2018 Jan 30;4:5. doi: 10.1038/s41421-017-0005-y. eCollection 2018. Cell Discov. 2018. PMID: 29507753 Free PMC article.
-
WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating β-Catenin/MMP9-Mediated Signaling.Front Pharmacol. 2020 Feb 26;11:98. doi: 10.3389/fphar.2020.00098. eCollection 2020. Front Pharmacol. 2020. PMID: 32174831 Free PMC article.
References
-
- Howlader N., N. A., Krapcho M., Garshell J., Miller D., Altekruse S.F., Kosary C.L., Yu M., Ruhl J., Tatalovich Z. National Cancer Institute; 2014. SEER Cancer Statistics Review, 1975–2011.
-
- Clark E.A., Golub T.R., Lander E.S., Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000;406:532–535. - PubMed
-
- van Golen K.L., Wu Z.F., Qiao X.T., Bao L.W., Merajver S.D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res. 2000;60:5832–5838. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous